Overview

Exacerbation Study

Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This study compares indacaterol with tiotropium in terms of bronchodilation over 52 weeks
Phase:
Phase 3
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Tiotropium Bromide